Home > Financial Ratios > KREBS BIOCHEMICALS & INDUSTRIES

KREBS BIOCHEMICALS & INDUSTRIES
Core EBITDA Margin

    Back to All Ratios
COMMUNITY POLL
for KREBS BIOCHEMICALS & INDUSTRIES
Please provide your vote to see the results

KREBS BIOCHEMICALS & INDUSTRIES Last 5 Year Core EBITDA Margin History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Margin(%) -34.70-17.30-30.27-56.94-32.73

What is the latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES ?

The latest Core EBITDA Margin ratio of KREBS BIOCHEMICALS & INDUSTRIES is -34.70 based on Mar2025 Standalone results.
Year Core EBITDA Margin
Mar2025-34.70
Mar2024-17.30
Mar2023-30.27
Mar2022-56.94
Mar2021-32.73

How is Core EBITDA Margin of KREBS BIOCHEMICALS & INDUSTRIES Trending?

Years Core EBITDA Margin % Change
Mar2025 -34.7
Negative
Mar2024 -17.3
Negative
Mar2023 -30.27
Negative
Mar2022 -56.94
Negative
Mar2021 -32.73 -

Other Financial Ratios of KREBS BIOCHEMICALS & INDUSTRIES


Compare Core EBITDA Margin ratio of peers of KREBS BIOCHEMICALS & INDUSTRIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES ₹151.9 Cr 5.4% 1.2% -12.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹430,513.0 Cr -0.1% 3.4% -0.1% Stock Analytics
DIVIS LABORATORIES ₹170,614.0 Cr 1.6% -2.5% 8.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹128,245.0 Cr 0.8% -0.9% 13.5% Stock Analytics
CIPLA ₹122,555.0 Cr 1.3% -0.6% 3.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,803.0 Cr 1% 3.7% 2.7% Stock Analytics


KREBS BIOCHEMICALS & INDUSTRIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KREBS BIOCHEMICALS & INDUSTRIES

5.4%

1.2%

-12.4%

SENSEX

-0.5%

1%

4.6%


You may also like the below Video Courses